By Victoria Cavicchi,
Research Analyst

Within the life sciences industry, medical publications groups are tasked with a critical responsibility: sharing company findings and new scientific brand support details with the healthcare community.  To ensure that these key medical communications groups are working efficiently, companies should provide them with the resources needed to meet demands.  Whether teams are responsible for 5 or 500 publications per year, companies should right-size the staffing and budgets allocated to these efforts.  They should also consider company structure. Cutting Edge Information’s recent study on medical publications departments highlights how top-performing pharmaceutical and device organizations resource and measure performance across various high- and low-output team structures. Continue reading “Are You Ready to Optimize Your Medical Publications Department?” »


By Jacob Presson,
Senior Research Analyst

Building and managing payer relationships doesn’t always receive the same level of dedicated attention as that of KOL relationships.  However, at the end of the day, nurturing these relationship types can have a similar level of impact.  A product’s pricing can be largely dependent on the quality of the relationship cultivated between the managed markets account manager and their contact within the insurer or hospital. Continue reading “Three Key Principles in Managing Payer Relationships” »


By Ryan McGuire,
Head of Research

The uses for Big Data in pharma are limitless.  Commercial, clinical and market access teams can all benefit from Big Data insights.  With so many options, it’s no wonder some companies get decision paralysis and don’t know where to begin.  The first step is to define the corporate objectives of the Big Data initiative.  Continue reading “Possibilities Abound for Big Data in Pharma” »


By Ryan McGuire,
Head of Research

Call centers are big business and very important communication tools for pharma companies.  US call center budgets can top $4 million a year and medical information managers should take care to monitor pharma call center performance metrics closely. The first step is to decide which call center KPIs are most important to your company. Continue reading “Know Your Pharma Call Center Performance Metrics” »


By Victoria Cavicchi,
Research Analyst

Ending product patents and generic competition are very real challenges in the pharmaceutical landscape. With limited counter-generics strategies, partnerships with generics companies can be an effective solution for organizations looking to maximize lifetime revenue for their branded products.  While these tactics can have great returns, they do require a high-level of investment and foresight—making them difficult to execute. Continue reading “Using the Buddy System: Finding a Quality Partner for Generics and Counter-Generics Strategies” »

By Natalie DeMasi,Research Analyst

Clinical research associates (CRAs) are a crucial part of a company’s clinical trial staffing. CRAs often work as a liaison between the company and investigator sites, ensuring that the trials run smoothly. As such, CRA responsibilities range from tracking patient consent forms to monitoring patient data and visiting investigator sites. Cutting Edge Information’s recent study on clinical trials finds that when recruiting CRAs, companies consider a number of qualities, including: Continue reading “Clinical Trial Staffing: Recruiting CRAs Best Suited to Trial Needs” »


By Sarah Ray,
Research Analyst

Patient recruitment isn’t just human subjects. Cutting Edge Information has conducted a number of clinically focused projects, examining an array of industry challenges.  How companies recruit for their clinical trials — including what works and what doesn’t — is a hot topic for clinical stakeholders.  A recent CEI study on patient recruitment highlights the percentage of companies conducting activities and who specifically —trial site, sponsor or CRO — is coordinating these activities. Continue reading “All Right, Meow: Patient Recruitment for Animal Health Studies is Serious Business” »


By Natalie DeMasi, Research Analyst

In this era of increasing healthcare spending scrutiny, the onus is on managed markets account managers to deliver a persuasive payer value proposition.  In meetings about formularies, payers will want to see not only product efficacy but also health economics data and comparative effectiveness research (CER).  These value propositions require a great deal of scientific expertise, and this is where medical science liaisons (MSLs), health outcomes liaisons (HOLs) and managed care liaisons (MCLs) come in handy. Continue reading “Delivering a Payer Value Proposition in Managed Markets: The Role of MSLs, MCLs and HOLs” »


By Sarah Ray,
Research Analyst

Medical publications help companies to communicate clinical trial findings, provide internal marketing support and educate the scientific community. To optimize strategic medical publications management, dedicated teams should be selective so that manuscripts are sent to the right scientific journals.  When selecting a journal, companies may consider its impact factor, readership profile and cost. Continue reading “Strategic Medical Publications Management: Selecting the Best-Fit Scientific Journals for Manuscript Submissions” »


By Victoria Cavicchi,
Research Analyst

Health economics and outcomes research (HEOR) groups have carved out their place in life sciences organizations throughout the industry. Though pharmaceutical and biotech companies have long-since accepted the utility of this function, many medical device companies have leveraged other groups to perform HEOR tasks — often ad hoc. Now, HEOR’s prominence is more widespread, and device companies are structuring health economics staff to take on a number of reimbursement-related responsibilities. One of these teams’ most prominent activities is aiding interactions with government and private medical device payers. Continue reading “Protecting Profitability: Translating Strong Health Economics and Outcomes Research to Drive Interactions with Medical Device Payers and More” »